Verona Pharma (VRNA)

VRNA trades at $105.63, 32.0% above the near-term max pain of $80 expiring Sep 19, 2025 (31 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($50-$100), signaling increased put positioning or downside protection. Key magnetic zone at 100 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for VRNA shows a downward trend from 100 to 50, indicating bearish sentiment or hedging activity. The 60% spread signals divergent expectations across timeframes. Most levels below 105.63 may cap rallies. Strong magnetic level at 100 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.